Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · IEX Real-Time Price · USD
3.660
-0.040 (-1.08%)
At close: Jul 19, 2024, 4:30 PM
3.540
-0.120 (-3.28%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Puma Biotechnology Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Puma Biotechnology stock has a target of 7.00, which predicts an increase of 91.26% from the current stock price of 3.66.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 4, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for PBYI is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +91.26% | Jun 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +91.26% | Jun 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +91.26% | May 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +91.26% | May 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +91.26% | Mar 1, 2024 |
Financial Forecast
Revenue This Year
223.04M
from 235.64M
Decreased by -5.35%
Revenue Next Year
216.27M
from 223.04M
Decreased by -3.04%
EPS This Year
0.25
from 0.45
Decreased by -45.15%
EPS Next Year
0.25
from 0.25
Increased by 0.41%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 230.5M | 246.9M | 262.1M | 215.3M | 210.0M |
| Avg | 223.0M | 216.3M | 214.1M | 209.1M | 204.0M |
| Low | 213.6M | 182.3M | 166.6M | 200.9M | 196.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.2% | 10.7% | 21.2% | 0.6% | 0.4% |
| Avg | -5.3% | -3.0% | -1.0% | -2.3% | -2.4% |
| Low | -9.3% | -18.3% | -23.0% | -6.1% | -6.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.32 | 0.55 | 0.67 | 0.05 | -0.05 |
| Avg | 0.25 | 0.25 | 0.30 | 0.05 | -0.05 |
| Low | 0.18 | 0.10 | 0.03 | 0.05 | -0.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -28.6% | 121.2% | 171.1% | -82.2% | - |
| Avg | -45.1% | 0.4% | 19.1% | -82.7% | - |
| Low | -60.8% | -60.3% | -88.1% | -83.4% | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.